Stay up-to-date with all of the life science events taking place in the Greater Boston area with the Science in Boston events calendar! From academia to industry and biotech to pharma, our events calendar is your complete source for life science conferences, symposiums, networking, and workshops in Boston. We even cover science pub nights and science fundraisers!
If you’re interested in promoting your life science event on the Science in Boston events calendar, please use our event submission form.
- This event has passed.
LabLinks: Targeting the DNA Damage Response in Cancer
July 17, 2020
Cell Press is pleased to introduce our first virtual LabLinks meeting on Targeting the DNA Damage Response in Cancer on Friday, July 17.
We had originally planned for this LabLinks to take place as an in-person event at the MGH Cancer Center in Boston, MA. Due to the current pandemic, this event will now be held entirely online via Zoom. We are delighted to welcome registrants globally to join us in this virtual format.
This LabLinks will cover a breadth of topics related to the DNA damage response in cancer, spanning basic molecular biology to clinical applications. Topics include:
• Basic molecular biology of the DDR
• The role of DNA repair protein mutations in promoting tumorigenesis
• Pre-clinical rationale for targeting the DDR as cancer therapy
• Clinical use of DNA damage agents in cancer
• Targeting the DDR to sensitize to immunotherapy
• Biomarkers of response to DNA damage therapies
• Tim Yap , MD Anderson Cancer Center, University of Texas
• Sharon Cantor (University of Massachusetts Medical School)
• Dipanjan Chowdhury (Dana-Farber Cancer Institute and Harvard Medical School)
• Alan D’Andrea (Dana-Farber Cancer Institute and Harvard Medical School)
• Andrew Elia (Harvard Medical School and Massachusetts General Hospital)
• Leif Ellisen (Massachusetts General Hospital)
• Catherine Freudenreich (Tufts University)
• Li Lan (Harvard Medical School and Massachusetts General Hospital)
• Shailja Pathania (University of Massachusetts Boston)
• Geoff Shapiro (Dana-Farber Cancer Institute and Harvard Medical School)
• Zuzana Tothova (Dana-Farber Cancer Institute, Harvard Medical School, and Broad Institute)
• Lee Zou (Harvard Medical School andMassachusetts General Hospital)
• Krista Bledsoe (Scientific Editor, Molecular Cell)
• Sejal Vyas (Scientific Editor, Cell Reports)
• Lee Zou (Harvard Medical School and Massachusetts General Hospital Cancer Center)